Your browser doesn't support javascript.
loading
Identification of risk groups for advanced liver fibrosis in the general population using the Fibrosis-3 index.
Kariyama, Kazuya; Kawanaka, Miwa; Nouso, Kazuhiro; Wakuta, Akiko; Shiota, Shohei; Kurisu, Akemi; Sugiyama, Aya; Akita, Tomoyuki; Kumada, Takashi; Tanaka, Junko.
Afiliação
  • Kariyama K; Department of Gastroenterology and Liver Disease Center Okayama City Hospital Okayama City Okayama Japan.
  • Kawanaka M; Department of General Internal Medicine 2 General Medical Center, Kawasaki Medical School Okayama City Okayama Japan.
  • Nouso K; Department of Gastroenterology and Liver Disease Center Okayama City Hospital Okayama City Okayama Japan.
  • Wakuta A; Department of Gastroenterology and Liver Disease Center Okayama City Hospital Okayama City Okayama Japan.
  • Shiota S; Department of Gastroenterology and Liver Disease Center Okayama City Hospital Okayama City Okayama Japan.
  • Kurisu A; Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University Hiroshima Japan.
  • Sugiyama A; Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University Hiroshima Japan.
  • Akita T; Department of Epidemiology Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University Hiroshima Japan.
  • Kumada T; Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki City Gifu Japan.
  • Tanaka J; Department of Nursing, Faculty of Nursing Gifu Kyoritsu University Ogaki City Gifu Japan.
JGH Open ; 8(7): e70010, 2024 Jul.
Article em En | MEDLINE | ID: mdl-39055237
ABSTRACT
Background and

Aim:

We conducted a study using the Fibrosis-3 (FIB-3) index, which is the established age-independent index of fibrosis in nonviral liver disease and addresses the limitations of the FIB-4 index in older age group, to assess the liver fibrosis risk among diverse demographic groups in the general population.

Methods:

We analyzed 31 327 individuals who underwent health examinations between 2013 and 2020 and investigated the distribution of the FIB-3 index by age group. In addition, we examined the age distribution of the FIB-3 index stratified by background factors, such as sex, body mass index (BMI), alcohol consumption habits, and the presence or absence of fatty liver.

Results:

In terms of age-specific distribution, the FIB-3 index remained below 1.5 in >90% of cases until the age of 50 years but exceeded 1.5 beyond the age of 50 years, in approximately 30% among those aged 70 years. Notably, the FIB-3 index above 31 years old was significantly higher in men than in women. Among the different BMI categories, individuals with BMI < 18.5 exhibited the highest prevalence of fibrosis. Habitual drinkers had a higher proportion with FIB-3. index ≥1.5, and some had FIB-3 index ≥2.5, raising the suspicion of advanced hepatic fibrosis. No distinct association was identified between the FIB-3 index and the presence of fatty liver.

Conclusions:

The FIB-3 index was useful for identifying cases of advancing hepatic fibrosis in a health checkup population. Liver fibrosis progresses with age in the general population, especially among men, those with low BMI, and habitual drinkers.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JGH Open Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JGH Open Ano de publicação: 2024 Tipo de documento: Article